Kiniksa Pharmaceuticals, Ltd. logo
Kiniksa Pharmaceuticals, Ltd. KNSA
$ 22.59 -1.83%

Quarterly report 2024-Q3
added 10-29-2024

report update icon

Kiniksa Pharmaceuticals, Ltd. Operating Income 2011-2024 | KNSA

Annual Operating Income Kiniksa Pharmaceuticals, Ltd.

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-25.2 M 9.77 M -157 M -157 M -170 M -108 M -65.4 M - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
9.77 M -170 M -96.1 M

Quarterly Operating Income Kiniksa Pharmaceuticals, Ltd.

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-9.66 M -117 K -16.5 M -10.9 M -3.15 M -11.2 M - 46.4 M -19.4 M -23.3 M - -30.7 M -40.6 M -49.3 M - -43.2 M -31.9 M -29.4 M - -30.4 M -39.3 M -67.6 M - -26.2 M -21.5 M -16.3 M - -16.2 M -11.4 M - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
46.4 M -67.6 M -21.8 M